Unusual manifestations of parvovirus B19 infection in children
Authors:
B. Ludíková 1; M. Luhový 2; E. Klásková 1; Z. Novák 1; F. Kopřiva 1; D. Pospíšilová 1
Authors place of work:
Dětská klinika Lékařské fakulty Univerzity Palackého a Fakultní nemocnice, Olomouc, přednosta prof. MUDr. V. Mihál, CSc.
1; Laboratoře Mikrochem Olomouc, a. s., Olomouc
2
Published in the journal:
Čes-slov Pediat 2012; 67 (3): 160-168.
Category:
Original Papers
Summary
Purpose of the study:
Parvovirus B19 is known as the cause of the „fifth disease” in preschool children, febrile infection with arthralgias, transient aplastic crisis in patients with hemolytic anemia and nonimmune hydrops fetalis. The aim of the work is to evaluate the course of parvovirus B19 infection in children with less common clinical manifestations that are not routinely described with respect to this infection.
Methods:
Parvovirus B19 infection was found in 8 patients with the following diagnoses: pericarditis with pleural effusions and thrombocytopenia, severe anemia with neutropenia, myocarditis with fulminant course and sudden onset of severe anemia requiring transfusion. Test for IgG and IgM antibodies (ELISA) and/or detection of the virus DNA by polymerase chain reaction were used to prove the infection.
Results:
In a patient with pericarditis, pleural effusions and thrombocytopenia, the parvovirus DNA was found in bone marrow and peripheral blood. Severe and protracted course of the infection led to the detection of congenital immunodeficiency: common variable immunodeficiency. Chronic iron deficiency anemia with increased demands on the turnover of erythropoiesis in another patient contributed to the development of severe anemia accompanied by neutropenia. In the patient with severe myocarditis, parvovirus infection was proven as late as from autopsy material. The course of parvoviral myocarditis in children can, in rare cases, be very severe and can have a fatal outcome. Parvovirus infection was, serologically and/or by evidence of the virus DNA, demonstrated in 5 patients with acute severe anemia, in whom previously unrecognized hereditary spherocytosis was found later.
Conclusion:
The abovementioned cases demonstrate the variability of clinical symptoms of parvovirus B19 infection which mainly depend on the immunological profile of the host and the current demands on the turnover of erythropoiesis.
Key words:
parvovirus B19, polymerase chain reaction, pericarditis, pleural effusions, myocarditis, transient aplastic crisis, anemia, neutropenia, hereditary spherocytosis
Zdroje
1. Cossart Y. Parvovirus B19 finds a disease. Lancet 1981; 2: 988–989.
2. Heegaard ED, Brown KE. Human parvovirus B19. Clin Micorb Rev 2002; 15: 485–505.
3. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K. Human parvovirus B19 nonstructural(NS1) protein induces apoptosis in erythroid lineage cells. J Virol 1998; 72: 3018–3028.
4. Young NS, Brown KE. Parvovirus B19. NEJM 2004; 350: 586–597.
5. Weigel-Kelley KA, Yoder MC, Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: Requirement of functional activation of beta1 integrin for viral entry. Blood 2003; 102: 3927–3933.
6. Munakata Y, Saito-Ito T, Kumura-Ishii K, Huang J, Kodera T, et al. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 2005; 106: 3449–3456.
7. de Jong EP, Walther FJ, Kroes AC, Oepkes D. Parvovirus B19 infection in pregnancy: new insights and management. Prenat Diagn 2011; 31 (5): 419–425.
8. Lehman HW, Knoll A, Kuster RM, Modrow S. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases in childhood. Arthritis Rheum 2003; 48: 1631–1638.
9. Pankuweit S, Ruppert V, Eckhardt H, Strache D, Maisch B. Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19. J Vet Med B Infect Dis Vet Publ Health 2005; 52 (7–8): 344–347.
10. Hatakka A, Klein J, He R, Piper J, Tam E, Walkty A. Acute hepatitis as a manifestation of parvovirus B19 infection. J Clin Microbiol 2011; 49 (9): 3422–3424.
11. Meyer P, Jeziorski E, Bott-Gilton L, Foulongne V, Rivier F, et al. Childhood parvovirus B19 encephalitis. Arch Pediatr 2011; 18 (12): 1310–1314.
12. Wen JQ, Zhou N, Li D, Feng HL, Wang H. Study on clinical characteristics and follow-up visit of acquired aplastic anemia associated with parvovirus B19 onfection. Indian J Pediatr 2011; (Epub ahead of print).
13. Gutermuth J, Nadas K, Zirbs M, Seifert F, Hein R, et al. Papular-purpuric gloves and socks syndrome. Lancet 2011; 378 (9786): 198.
14. Chuhjo T, Nakao S, Matsuda T. Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulin. Am J Hematol 1999; 60: 222–224.
15. Menezes MD, McCarter R, Greene EA, Bauman NM. Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial. Ann Otol Rhinol Laryngol 2011; 120 (10): 686–695.
16. Sairam S, Goel N, Lisse J, McNearney T. Pericardial effusion and cardiomyopathy following arthritis with parvovirus B19 infection: response to intravenous immunoglobulin. J Clin Rheumatol 2001; 7 (5): 346–349.
17. Ergül Y, Nişli K, Keleşoğlu F, Dindar A. Acute pericarditis and transient erythroblastopenia associated with human parvovirus B19 infection. Turk Kardiyol Dern Ars 2010; 38 (5): 349–351.
18. Sato T, Ueda D, Sakota S, Haseyama K, Chiba S, Kudoh T. Pancytopenia with hemophagocytosis secondary to parvovirus B19 infection in a family with hereditary spherocytosis. Pediatr Int 1999; 41 (5): 561–564.
19. Shirono K, Tsuda H. Parvovirus B19-associated haemophagocytic syndrome in healthy adults. Br J Haematol 1995; 89 (4): 923–926.
20. Mogensen TH, Jensen JM, Hamilton-Dutoit S, Larsen CS. Chronic hepatitis caused by persistent parvovirus B19 infection. BMC Infect Dis 2010; 10: 246.
21. Mihal V, Dusek J, Hajduch M, Cohen BJ, Fingerova H, Vesely J. Transient aplastic crisis in a leukemic child caused by parvovirus B19 infection. Pediatr Hematol Oncol 1996; 13: 173–177.
22. Šrámková L, Sedláček P, Pospíšilová D, Petrtýlová K, Starý J. Bone marrow transplantation and postransplant care in Diamond-Blackfan anemia: report of three cases. Abstract. European Society of Pediatric Haematology and Immunology Annual Meeting, Luzern 6/2001. Pediatr Res 2001; 49 (6).
23. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006; 114 (15): 1581–1590.
24. Dettmeyer R, Kandolf R, Baasner A, Banaschak S, Eis-Hubinger AM, Madea B. Fatal parvovirus B10 myocarditis in an 8-year boy. J Forensic Sci 2003; 48 (1): 183–186.
25. Zack F, Klingel K, Kandolf R, Wegener R. Sudden cardiac death in a 5-year-old girl associated with parvovirus B19 infection. Forensic Sci Int 2005; 155 (1): 13–17.
26. Munro K, Croxson MC, Thomas S, Wilson NJ. Three cases of myocarditis in childhood associated with human parvovirus(B19 virus). Pediatr Cardiol 2003; 24 (5): 473–475.
27. Amabile N, Fraisse A, Bouvenot J, Chetaille P, Ovaert C. Outcome of acute fulminant myocarditis in children. Heart 2006; 92 (9): 1269–1273.
28. Tschope C, Bock CT, Kasner M, Noutsias M, Westermann D, et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 2005; 111 (7): 879–886.
29. Baasner A, Dettmeyer R, Graebe M, Rissland J, Madea B. PCR-based diagnosis of enterovirus and parvovirus B19 in paraffin-embedded heart tissue of children with suspected sudden infant death syndrome. Lab Invest 2003; 83 (10): 1451–1455.
30. Dettmeyer R, Baasner A, Schlamann M, Padosch SA, Haag C, et al. Role of virus-induced myocardial affections in sudden infant death syndrome: a prospective postmortem study. Pediatr Res 2004; 55 (6): 947–952.
31. Kandolf R. Virus etiology of inflammatory cardiomyopathy. Dtsch Med Wochenschr 2004; 129 (41): 2187–2192.
32. Aziz KU, Patel N, Sadullah T, Tasneem H, Thawerani H, Talpur S. Acute viral myocarditis: role of immunosuppression: a prospective randomised study. Cardiol Young 2010; 20 (5): 509–515
33. Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child 2004; 89 (6): 580–584.
34. Tarantino MD, Shahidi NT. Parvovirus B19-induced red blood cell aplasia complicating iron-deficiency anemia. Clin Pediatr (Phila) 1995; 34 (2): 108–109.
35. Nesher G, Moore TL. Human parvovirus infection. Infect Med 1997; 14: 638–642.
Štítky
Neonatology Paediatrics General practitioner for children and adolescentsČlánok vyšiel v časopise
Czech-Slovak Pediatrics
2012 Číslo 3
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Unusual manifestations of parvovirus B19 infection in children
- Pyruvate kinase deficiency in children
- Variability in clinical manifestation of noroviral infection in a newborn: from fulminant necrotizing enterocolitis to asymptomatic course
- Benign infantile seizures associated with noroviral gastroenteritis